Tender Number 1

This tender, identified as Tender Number 1, pertains to the procurement of specific pharmaceutical products. The contract (sub-contract) includes the following medication: ATC Code N07XX21, with the generic name Eplontersen. It is an injection solution with a strength of 45 mg, and the unit value is 1.5 mg. The estimated quantity required is 999 units. Each tender number is considered an independent sub-contract and is tendered separately from others. Consequently, a supplier has the option to bid on one, several, or all tender numbers, with awards being made independently for each individual tender number. A supplier may therefore be awarded one, several, or all sub-contracts. Suppliers are referred to the tender conditions for further details, including information on submitting bids for individual tender numbers. The "quantity in units" stated above represents an estimated consumption of the medicines under this tender number; however, the actual consumption may deviate significantly. Suppliers must take this into account, as these medicines are intended for patient treatment in public hospitals, where patient needs must be met. For a more detailed description, please refer to the tender conditions and the framework agreement.

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals. Located in Denmark, Europe, this opportunity is open to firms and consortiums, with an estimated budget of DKK 26.0 million.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.